Kidney Genetics: Continuing Discoveries and a Roadmap to the Clinic
- PMID: 36758119
- PMCID: PMC10103286
- DOI: 10.1681/ASN.0000000000000077
Kidney Genetics: Continuing Discoveries and a Roadmap to the Clinic
Abstract
This article contains a podcast at
Conflict of interest statement
J.R. Sedor reports consultancy: Boehringer Ingelheim; Research Funding: Calliditas, Goldfinch Bio, Novartis, and Travere for clinical trials; Honoraria: Boehringer Ingelheim; Patents or Royalties: APOL1 transgenic mice licensed to Sanofi Genzyme; Invention disclosure for machine learning analysis of kidney biopsies; Advisory or Leadership Role: Kidney Foundation of Ohio—kidney patient organization for direct aid—Board of Directors, NephCure Kidney International, Chair Kidney X Steering Committee; and Other Interests or Relationships: Editorial Boards—Seminars in
Comment on
-
Genomic Disorders in CKD across the Lifespan.J Am Soc Nephrol. 2023 Apr 1;34(4):607-618. doi: 10.1681/ASN.2022060725. Epub 2022 Oct 27. J Am Soc Nephrol. 2023. PMID: 36302597 Free PMC article.
-
A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases.J Am Soc Nephrol. 2023 Apr 1;34(4):706-720. doi: 10.1681/ASN.0000000000000076. Epub 2023 Jan 17. J Am Soc Nephrol. 2023. PMID: 36753701 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources